Key result
Carvedilol at doses of 0.03, 0.1, and /kg reduced the incidence of lethal ventricular fibrillation to 0%, 0%, and 10%, respectively, compared to 90% in controls.
Why the study?
Does carvedilol prevent lethal ventricular fibrillation induced by coronary reperfusion in anesthetized rats?
Does carvedilol prevent lethal ventricular fibrillation induced by coronary reperfusion in anesthetized rats?
Carvedilol effectively inhibits reperfusion-induced lethal ventricular fibrillation in an in vivo rat model, likely through combined beta-blocking and antioxidant mechanisms.
Answers are grounded in this paper and cite their sources.
Carvedilol's anti-VF effect in rats is hypothesis-generating; does not support clinical use pending human trials.
BACKGROUND: Previous study has shown the antiarrhythmic effects of carvedilol on isolated rat hearts, but little is known about the mechanism of this protective action. This article examines the inhibitory effect of carvedilol against arrhythmias induced by reperfusion in anesthetized rats. In addition, the results are compared with those with propranolol, superoxide dismutase (SOD) plus catalase, and a combination of both in order to elucidate the mechanism of the protective actions. METHODS AND MATERIALS: Ninety percent of the rats in the control group showed lethal ventricular fibrillation (VF). Carvedilol at the doses of 0.03, 0.1, and 0.3 mg/kg significantly reduced the incidence of lethal VF to 0%, 0%, and 10%, respectively (P <.05). In contrast, propranolol at the doses of 0.3, 1.0, and 3.0 mg/kg and SOD (35,000 units/kg) plus catalase (400,000 units/kg) did not reduce the incidence of lethal VF (80%, 60%, 70%, and 70%, respectively). However, administration of a combination of propranolol (1.0 mg/kg) and SOD plus catalase completely inhibited the occurrence of lethal VF to 0% (P<.05). CONCLUSION: These results indicate that carvedilol has the inhibitory effect against reperfusion arrhythmias in rats and suggest that the mechanism of action of this compound is related to the combined effects of beta-blocking and antioxidant.
No takes yet. Share an insight, caveat, or question.
Takusagawa et al. (2000) studied Arrhythmias induced by coronary reperfusion. Carvedilol vs. Control, propranolol, SOD plus catalase, and combination of propranolol and SOD plus catalase was evaluated on Incidence of lethal ventricular fibrillation (VF) (p=<.05). Carvedilol at doses of 0.03, 0.1, and /kg reduced the incidence of lethal ventricular fibrillation to 0%, 0%, and 10%, respectively, compared to 90% in controls.
Synapse has enriched 10 related papers. Consider them for comparative context: